Jason Gorevic, Teladoc CEO
February 21, 2024 10:45 PM EST
Health Tech

Teladoc is­n't ex­pect­ing to grow as fast as in­vestors ex­pect­ed, cast­ing a cloud on the fu­ture of tele­health

Ngai Yeung

Health Tech Reporter

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)

One of the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Roche no longer wants to be where ‘DNA se­quenc­ing goes to die’

Trump’s HHS de­fends drug price ne­go­ti­a­tions in No­var­tis suit

First meet­ing of CDC vac­cine ad­vi­sors in the Kennedy era is post­poned

Trump’s picks for NIH, CMS say they’ll un­load in­dus­try in­vest­ments

How Keymed steered the Chi­na-to-US New­Co mod­el in biotech

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times